{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"TsTb8NyOS2\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23505\/\">Not\u00edcias e notas de sa\u00fade animal de 22 de fevereiro de 2002<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/23505\/embed\/#?secret=TsTb8NyOS2\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for February 22, 2002&#8221; &#8212; Brakke Consulting Website\" data-secret=\"TsTb8NyOS2\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 22, 2002 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &nbsp; &gt;&nbsp; Akzo Nobel reported that year-end 2001 sales for its animal health division Intervet were 1,096 million euros ($971 million), an increase of 7% over year-end 2000.&nbsp; The company closed the year on a record performance, and is reported to be earning margins in line with Akzo Nobel&rsquo;s human healthcare business.&nbsp; (company website) &gt;&nbsp; Heska reported financial results for the fourth quarter and year 2001.&nbsp; For the quarter, revenues increased 29% to $14.7 million, while net loss was $5.6 million compared with $5.5 million in the fourth quarter 2000.&nbsp; For the year, revenues were $48.3 million compared with $52.7 million in 2000.&nbsp; The prior year revenue included $3.2 million from two businesses that were sold in 2000 and $1.3 million from the sale of rights to one of the company&rsquo;s products.&nbsp; The net loss in 2001 was $18.7 million compared with net loss of $21.9 million in the prior year. (company press release) &gt;&nbsp; VCA Antech, Inc. reported financial results for its fourth quarter and year ended December 31, 2001. Revenue for the fourth quarter ended December 31, 2001 increased 12.4% to a record $96.0 million from revenue of $85.4 million in the same quarter last year. ForView Full Post;"}